Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 445,764 | 361,051 | 296,536 | 219,514 | 117,483 |
| Cost of Goods | 147,619 | 131,367 | 120,855 | 74,400 | 41,455 |
| Gross Profit | 298,145 | 229,684 | 175,681 | 145,114 | 76,028 |
| Operating Expenses | 282,622 | 315,846 | 217,617 | 227,417 | 111,872 |
| Operating Income | 16,142 | -85,795 | -41,081 | -81,903 | -35,389 |
| Other Income | 9,602 | 9,183 | 4,654 | 254 | 480 |
| Pre-tax Income | 25,744 | -76,612 | -36,427 | -81,649 | -34,909 |
| Income Tax | 1,606 | -2,208 | 133 | -6,086 | N/A |
| Net Income Continuous | 24,138 | -74,404 | -36,560 | -75,563 | -34,909 |
| Net Income | $24,138 | $-74,404 | $-36,560 | $-75,563 | $-34,909 |
| EPS Basic Total Ops | 0.32 | -1.02 | -0.51 | -1.11 | -0.66 |
| EPS Basic Continuous Ops | 0.32 | -1.02 | -0.51 | -1.11 | -0.66 |
| EPS Diluted Total Ops | 0.31 | -1.02 | -0.51 | -1.11 | -0.66 |
| EPS Diluted Continuous Ops | 0.31 | -1.02 | -0.51 | -1.11 | -0.66 |
| EPS Diluted Before Non-Recurring Items | 0.73 | -0.28 | -0.51 | -0.49 | -0.66 |
| EBITDA(a) | $39,601 | $-58,607 | $-15,153 | $-62,310 | $-27,445 |